FDA conducts Capacity Building Training Programme for AYUSH Stakeholders

  1. Home
  2. Politics
  3. FDA conducts Capacity Building Training Programme for AYUSH Stakeholders

Directorate of Food and Drugs Admn, Bambolim-Goa, in association with Pharmacopoeia Commission for Indian medicine & Homoeopathy (PCIM & H), Ministry of AYUSH, Govt. of India, Ghaziabad, organized two days “Regulatory Capacity Building, Training Programme, on quality control/regulatory enforcement for Ayurveda, Siddha & Unani drugs for the Technical Personnel in AYUSH industry at Goa, the regulatory staff at FDA and AYUSH Doctors at DHS at conference Hall, Directorate of food Drugs Administration, Bambolim on  Sept 30 & Oct 01, 2021.

Dr Jose, DSa, Director, Directorate of Health Services, Government of Goa, was the Chief Guest and Dr.  Datta  Bhat  Dy. Director, DHS, was the Guest of Honour.

Dr. P. K Prajapati, Director incharge of Pharmacopoeia Commission for Indian Medicine & Homoeopathy, Ministry of AYUSH Govt. of India, Ghaziabad was also present on the occasion.

Chief guest Dr. Jose D`sa, said that after the formation of the Ministry of AYUSH Ayurveda and other Indian System of Medicines have received the due recognition. More than 150 AYUSH doctors are engaged with Goa Government, and served during Covid-19 Pandemic. Consulting at AYUSH OPDs & free dispensing of quality medicines are available at all health centres.

Prof Dr. P. K. Prajapati stressed the importance of Standardization of AYUSH medicines. He also spoke on the need to avoid misleading advertisements with respect to AYUSH drugs.

Dr. Datta Bhatt, Dy Director AYUSH, informed that Ministry of AYUSH has made provision of funds for promotion and propagation of AYUSH medicines.

The Ministry, through the National AYUSH Mission programme, granted funds to the Directorate of Food & Drugs Administration for Quality Control of AYUSH medicines.

Smt Jyoti Sardesai, Director, DFDA, emphasized on the need of following Good Manufacturing Practices, Good Laboratory Practices, Good warehousing and documentation practices.  Producing safe, efficacious and right quality medicines should be strictly followed by the manufacturers to ensure patient safety, she added.

Dr. G.V.R Joseph, who is working as Joint Director I/C at PCIM&H Ghaziabad, delivered a lecture on overview of drugs regulatory system in India for Ayurveda, Uniani, & Siddha Medicine and also on botanical identification of ASU drugs.

Dr. Devki Pant, Research officer(T) PCIM&H, Ghaziabad spoke on Standardization of ASU Drugs & formulations and Practical hands on Analytical studies in  ASU drugs.

Dr. M. Ramesh, Scientific Officer (M), PCIM&H, Ghaziabad explained the importance of microbiological studies in ASU drugs.

Welcome & Introductory speech was given by Dr. Mahesh Verlekar, State licensing Authority Ayurveda, Govt of Goa. Vote of thanks was proposed by Smt. Medha Dessai, Dy. Director, DFDA

Previous Post
Next Post